Hyperhomocysteinemia--the biochemical link between a weak heart and brittle bones?

Related Experiment Video

Updated: Aug 9, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Markus Herrmann1, Omid Taban-Shomal, Stefanie Müller

  • 1Institut für Klinische Chemie und Laboratoriumsmedizin / Zentrallabor, Universitätsklinikum des Saarlandes, Homburg / Saar, Germany. markusherr@aol.com

Clinical Laboratory
|April 6, 2006
PubMed

Insights

Mild to moderate hyperhomocysteinemia (HHCY) is linked to osteoporosis and chronic heart failure (CHF). Lowering homocysteine may improve outcomes for patients with these conditions.

Area of Science:

  • Gerontology
  • Cardiology
  • Endocrinology

Background:

  • Osteoporosis, chronic heart failure (CHF), and hyperhomocysteinemia (HHCY) are prevalent in the elderly.
  • These conditions often coexist, posing a growing public health challenge due to demographic shifts.
  • Hyperhomocysteinemia is increasingly recognized as an independent risk factor for both CHF and osteoporosis.

Purpose of the Study:

  • To review the existing literature on the relationship between HHCY and osteoporosis.
  • To review the existing literature on the relationship between HHCY and CHF.
  • To explore potential biochemical mechanisms linking HHCY to both conditions and discuss therapeutic implications.

Main Methods:

  • Literature review of studies on HHCY, osteoporosis, and CHF.
  • Analysis of proposed biochemical pathways connecting HHCY to cardiovascular and bone health.
  • Synthesis of findings to evaluate HHCY as a common risk factor and therapeutic target.

Main Results:

  • HHCY is independently associated with an increased risk of both osteoporosis and CHF.
  • The underlying mechanisms linking HHCY to these distinct diseases are not well understood.
  • Shared biochemical pathways may connect HHCY's effects on bone and heart health.

Conclusions:

  • HHCY may represent a common risk factor for osteoporosis and CHF.
  • Understanding the link between HHCY, heart failure, and bone disease is crucial.
  • Homocysteine-lowering therapy holds potential therapeutic benefits for patients with CHF and osteoporosis.

More Related Videos

Measurement of Heme Synthesis Levels in Mammalian Cells09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
What is the Skeletal System?01:02

What is the Skeletal System?

Overview